Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide vs Propranolol in Migraine
NCT06361446Phase 3Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of zonisamide in migraine (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Change in migraine days per 28 days. Started Mar 2024; status: recruiting.
02
Drugs
zonisamide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06361446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06361446.